Business Wire

Treace Medical Announces Presentation of Positive Clinical Data Supporting Lapiplasty® 3D Bunion Correction™ for the Surgical Management of Bunion Deformities

PONTE VEDRA, Fla.--(BUSINESS WIRE)--Treace Medical Concepts, Inc., a medical device company focused on advancing the standard of care for hallux valgus (bunion) surgery, announces presentation of ...
Business Wire

Treace Medical Announces Enrollment of the First Patient in the ALIGN3D™ Post-Market Clinical Study of Lapiplasty® 3D Bunion Correction™

PONTE VEDRA, Fla.--(BUSINESS WIRE)--Treace Medical Concepts, Inc., a medical device company focused on advancing the standard of care for hallux valgus (bunion) surgery, today announced the initiation ...
Seeking Alpha

Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study

PONTE VEDRA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts (TMCI), Inc. , a medical technology company driving a fundamental shift in the surgical treatment of bunions and related ...
Business Insider

Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Stockhouse

Treace Announces Interim 3-Year ALIGN3D(TM) Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology ...
manilatimes

Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study

PONTE VEDRA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace” or the "Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...